Central nervous system exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous dosing in mice

BACKGROUND: The clinical use of mefloquine (MQ) has declined due to dose-related neurological events. Next generation quinoline methanols (NGQMs) that do not accumulate in the central nervous system (CNS) to the same extent may have utility. In this study, CNS levels of NGQMs relative to MQ were mea...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Dow, Geoffrey S, Milner, Erin, Bathurst, Ian, Bhonsle, Jayendra, Caridha, Diana, Gardner, Sean, Gerena, Lucia, Kozar, Michael, Lanteri, Charlotte, Mannila, Anne, McCalmont, William, Moon, Jay, Read, Kevin D, Norval, Suzanne, Roncal, Norma, Shackleford, David M, Sousa, Jason, Steuten, Jessica, White, Karen L, Zeng, Qiang, Charman, Susan A
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2011
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3128011/
https://ncbi.nlm.nih.gov/pubmed/21645370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-10-150
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items